Learn, Analyse & Invest
only with
only with
+91
Download Orca
Gujarat Inject (Kerala) Ltd.
Guj. Inject (Kerala)
Gujarat Inject (Kerala) Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap - With a market cap of ₹1.43 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results |
| 14 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 28 05 2022 | Audited Results |
| 13 08 2022 | Quarterly Results |
| 07 09 2022 | Issue Of Warrants |
| 14 09 2022 | Issue Of Warrants |
| 08 11 2022 | Quarterly Results |
| 10 11 2022 | Quarterly Results (Revised) |
| 10 02 2023 | Quarterly Results |
| 22 05 2023 | Quarterly Results & Audited Results |
| 14 08 2023 | Quarterly Results |
| 03 11 2023 | Quarterly Results & Preferential Issue of shares Inter alia, approved: 1) To consider the proposal for raising funds by way of issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including the approval of the shareholders of the Company, and 2) Any other items as may be decided by the Board of Directors The Board, would also consider conducting a general meeting/extraordinary general meeting/postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal, if required. |
| 06 11 2023 | Quarterly Results |
| 22 11 2023 | Inter alia, approved:- (1) To discuss and consider acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited, subject to obtaining requisite approval of the shareholders of the Company; (2) To Discuss, consider and approve an increasing borrowing limits in excess of the limit specified under section 180(1)(c) of Companies Act, 2013, subject to obtaining requisite approval of the shareholders of the Company; (3) Any other items of business; |
| 16 12 2023 | Preferential Issue of shares |
| 13 02 2024 | Quarterly Results |
| 22 10 2024 | Quarterly Results |
| 23 01 2025 | Quarterly Results |
| 05 02 2025 | Stock Split |
| 18 02 2025 | Stock Split |
| 20 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 13 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
| 20 05 2026 | Audited Results |
| 15 07 2026 | Quarterly Results |